<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Respir Med Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">Respir Med Case Rep</journal-id><journal-title-group><journal-title>Respiratory Medicine Case Reports</journal-title></journal-title-group><issn pub-type="epub">2213-0071</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32399393</article-id><article-id pub-id-type="pmc">7215148</article-id><article-id pub-id-type="publisher-id">S2213-0071(20)30117-9</article-id><article-id pub-id-type="doi">10.1016/j.rmcr.2020.101087</article-id><article-id pub-id-type="publisher-id">101087</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>The potential role of TNF&#x003b1; in 2019 novel coronavirus pneumonia</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Ye</surname><given-names>Wenjing</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Lu</surname><given-names>Saisai</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>xue</surname><given-names>Ali</given-names></name><email>2281324605@qq.com</email><xref rid="aff3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>Rheumatology Department, Huashan Hospital, Fudan University, Shanghai, China</aff><aff id="aff2"><label>b</label>Rheumatology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China</aff><aff id="aff3"><label>c</label>Hematology and Rheumatology Department, Ruian City People's Hospital, Ruian, China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Department of Hematology and Rheumatology, Ruian City People's Hospital, Wansong Road, Ruian, 325200, China. <email>2281324605@qq.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>12</day><month>5</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>12</day><month>5</month><year>2020</year></pub-date><volume>30</volume><elocation-id>101087</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>5</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/AS%20(Ankylosing%20Spondylitis)/" id="intref0010">Ankylosing Spondylitis</ext-link> (AS), who was a biological agent (anti-TNF&#x003b1;) user in Wenzhou, China, and describe the clinical course and management of the case.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>2019 novel coronavirus</kwd><kwd>Rheumatic disease</kwd><kwd>Tumor necrosis factor-&#x003b1;</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">On December 31, 2019, a novel coronavirus infection erupted in Wuhan, China, and spread rapidly [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib2" ref-type="bibr">2</xref>]. As of March 4, 2020, a total of 80,424 cases had been reported in China, with 2984 fatal cases. But all the 504 cases that reported in Wenzhou, China, only two had a history of rheumatic disease, as we knew. Here we report 1 case of an <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/AS%20(Ankylosing%20Spondylitis)/" id="intref0015">Ankylosing Spondylitis</ext-link> (AS) patient under anti-TNF&#x003b1; therapy infected with 2019 novel coronavirus (2019-nCoV).</p><p id="p0015">Written consent was provided from the patient included in this report. The Ruian City People's Hospital institutional review board (IRB) does not require IRB approval for case report describing 1 patient.</p><sec id="sec1.1"><label>1.1</label><title>Case presentation</title><p id="p0020">On January 25, 2020, a 48-year-old male who suffered from fever for 3 days went to local hospital to see a doctor. His highest body temperature reached 39&#x000a0;&#x000b0;C, accompanied with chills, cough and fatigue. He disclosed that he had close contact with his son who had returned to Ruian on January 17 from Wuhan, China. Chest radiography, blood routine and 2019-nCoV <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/nucleic%20acid/" id="intref0020">nucleic acid</ext-link> test was undertaken with suspected novel coronavirus pneumonia (NCP). Only stripes of the lower lobe of the left lung was found by the chest radiography (<xref rid="fig1" ref-type="fig">Fig. 1</xref>a). One day later, the Centers for Disease Control and Prevention (CDC) of Wenzhou confirmed that the patient's oropharyngeal swabs tested positive for 2019-nCoV. On January 28, 2020, the patient was admitted to an airborne-isolation unit at local hospital.<fig id="fig1"><label>Fig. 1</label><caption><p>a) Posteroanterior Chest Radiographs, January 25, 2020. b&#x02013;f: Computerized Tomography. b) January 28, 2020; c) January 31, 2020; d) February 04, 2020; e) February 06, 2020; f) February 14, 2020.</p><p>a: Stripes shadow of the lower lobe of the left lung.</p><p>b-c: Infiltrates shadows in the lung bases were visible, indicating likely atypical pneumonia; the infiltrates lesions have steadily increased over time.</p><p>d-f: the previous bilateral lower-lobe infiltrates lesion absorption as time passed by.</p></caption><alt-text id="alttext0015">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig></p><p id="p0025">The patient had a history of AS for 2 years and using Tumor Necrosis Factor-&#x003b1;(TNF-&#x003b1;) inhibitor to control disease (25mg per times, 8 times for the first month, 4 times for the second month, then reduced to 2 times one month, and recently 1 times every 50 days, the last injection was 50 days ago). In addition, he had a history of hypertriglyceridemia and hypertension, but no history of smoking. The physical examination revealed no obvious abnormalities. After admission, the patient received supplemental oxygen, antiviral (lopinavir and ritonavir tablets, <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/interferon/" id="intref0025">interferon</ext-link> &#x003b1;2&#x003b2;) and antibacterial (<ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/moxifloxacin/" id="intref0030">moxifloxacin</ext-link>) therapy.</p><p id="p0030">On days 2 through 7 of hospitalization, the patient continued to report a nonproductive cough, fatigued and intermittent fevers, followed by abdominal discomfort and <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/diarrhea/" id="intref0035">diarrhea</ext-link>. Laboratory results on hospital days 2 showed elevated levels of creatine kinase, <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/ferritin/" id="intref0040">ferritin</ext-link>, C-reactive protein (CRP) and <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/erythrocyte%20sedimentation%20rate%20(ESR)/" id="intref0045">erythrocyte sedimentation rate (ESR</ext-link>), lower percentage of lymphocytes. Computerized tomography (CT) taken on hospital day 1 showed infiltrates in lower lobe of both lung (<xref rid="fig1" ref-type="fig">Fig. 1</xref>b). A second CT from hospital day 4 showed more obvious evidence of pneumonia (<xref rid="fig1" ref-type="fig">Fig. 1</xref>c), and arbidol tablets was added to strengthen antiviral therapy.</p><p id="p0035">A third CT (hospital day 8) showed no obviously improvement of the pneumonia (<xref rid="fig1" ref-type="fig">Fig. 1</xref>d). Then <ext-link ext-link-type="uri" xlink:href="http://dict.youdao.com/w/methylprednisolone/" id="intref0050">methylprednisolone</ext-link> 80 mg daily was added to alleviate alveolar inflammation, which was reduced regularly. Rechecked CT (hospital day 10 and day 18) showed the previous infiltrates lesion absorption (<xref rid="fig1" ref-type="fig">Fig. 1</xref>e and <xref rid="fig1" ref-type="fig">f</xref>). On hospital day 14, the patient's oropharyngeal swabs tested negative for 2019-nCoV. On hospital day 18, the patient's clinical condition improved significantly.</p></sec></sec><sec id="sec2"><label>2</label><title>Discussion</title><p id="p0040">This case of report, to our knowledge, is the first case of 2019-nCoV infection in a AS patient who was a regular TNF-&#x003b1; inhibitor user. The dosing interval was a bit longer than usual usage due to low disease activity of AS. We found low incidence of NCP in rheumatic disease patient, and the reason remain unclear.</p><p id="p0045">Recent study reported that the pathological of 2019-nCoV manifested with increased CCR4+ Th17&#x000a0;cells which may lead to high levels of cytokine [<xref rid="bib3" ref-type="bibr">3</xref>]. Some studies also found patients infected with 2019-nCoV had high amounts of cytokine, including IL2, IL10, and TNF&#x003b1; [<xref rid="bib4" ref-type="bibr">4</xref>]. Pulmonary epithelia damage leading to respiratory distress syndrome (ARDS) can be a consequence of a cytokine storm, consist of IL-1&#x003b2;, TNF [<xref rid="bib5" ref-type="bibr">5</xref>]. Anti-TNF&#x003b1; may have a protect effect as a decrease in serum TNF-&#x003b1; and IL-1&#x003b2; is associated with decreased lung injury and lethality in rats [<xref rid="bib6" ref-type="bibr">6</xref>]. And earlier infliximab (anti-TNF&#x003b1; monoclonal antibody) administration is associated with better therapeutic result and prognosis in patient with dermatomyositis with acute interstitial pneumonia [<xref rid="bib7" ref-type="bibr">7</xref>]. Since no-specific treatment has been recommended for 2019-nCoV infection, anti-TNF&#x003b1; therapy may be a potential treatment for NCP.</p><p id="p0050">Despite its anti-inflammation effect, exposed to anti-TNF agent may increase risk of all infections, markedly bacterial and fungal opportunistic infections [<xref rid="bib8" ref-type="bibr">8</xref>,<xref rid="bib9" ref-type="bibr">9</xref>]. This patient had normal levels of cytokine, which may due to his pervious injection of TNF&#x003b1;. But the true role of TNF&#x003b1; in NCP remain unknown, and whether anti-TNF therapy is benefit for NCP need more real world data.</p></sec><sec id="sec3"><label>3</label><title>Conclusion</title><p id="p0055">In the study, we presented a case of patient with rheumatic disease under anti-TNF&#x003b1; therapy infected with 2019-nCoV. Anti-TNF therapy may have positive effect in NCP.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Holshue</surname><given-names>M.L.</given-names></name><name><surname>DeBolt</surname><given-names>C.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name><name><surname>Lofy</surname><given-names>K.H.</given-names></name><name><surname>Wiesman</surname><given-names>J.</given-names></name><name><surname>Bruce</surname><given-names>H.</given-names></name></person-group><article-title>First case of 2019 novel coronavirus in the United States</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>929</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">32004427</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Pathological findings of covid-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir. Med.</source><year>2020 Feb 18</year><comment>E-pub ahead of print</comment></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in wuhan, China</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Nieto-Torres</surname><given-names>J.L.</given-names></name><name><surname>DeDiego</surname><given-names>M.L.</given-names></name><name><surname>Verdia-Baguena</surname><given-names>C.</given-names></name><name><surname>Jimenez-Guardeno</surname><given-names>J.M.</given-names></name><name><surname>Regla-Nava</surname><given-names>J.A.</given-names></name><name><surname>Fernandez-Delgado</surname><given-names>R.</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis</article-title><source>PLoS Pathog.</source><volume>10</volume><year>2014</year><object-id pub-id-type="publisher-id">e1004077</object-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Yoshinari</surname><given-names>D.</given-names></name><name><surname>Takeyoshi</surname><given-names>I.</given-names></name><name><surname>Koibuchi</surname><given-names>Y.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Kawashima</surname><given-names>Y.</given-names></name><name><surname>Koyama</surname><given-names>T.</given-names></name></person-group><article-title>Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway</article-title><source>Crit. Care Med.</source><volume>29</volume><year>2001</year><fpage>628</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">11373433</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.B.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>X.C.</given-names></name></person-group><article-title>Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review</article-title><source>Rheumatol. Int.</source><volume>33</volume><year>2013</year><fpage>2455</fpage><lpage>2458</lpage><pub-id pub-id-type="pmid">23715693</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>M.S.</given-names></name><name><surname>Friedman</surname><given-names>L.N.</given-names></name></person-group><article-title>Tuberculosis and biologic therapies: anti-tumor necrosis factor-alpha and beyond</article-title><source>Clin. Chest Med.</source><volume>40</volume><year>2019</year><fpage>721</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">31731980</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Kirchgesner</surname><given-names>J.</given-names></name><name><surname>Lemaitre</surname><given-names>M.</given-names></name><name><surname>Carrat</surname><given-names>F.</given-names></name><name><surname>Zureik</surname><given-names>M.</given-names></name><name><surname>Carbonnel</surname><given-names>F.</given-names></name><name><surname>Dray-Spira</surname><given-names>R.</given-names></name></person-group><article-title>Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases</article-title><source>Gastroenterology</source><volume>155</volume><year>2018</year><fpage>337</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">29655835</pub-id></element-citation></ref></ref-list><sec id="appsec3"><title>CRediT authorship contribution statement</title><p id="p0070">Wenjing Ye: Conceptualization, Writing - original draft. Saisai Lu: Conceptualization, Writing - original draft, Resources, Writing - review &#x00026; editing. Ali xue: Supervision, Writing - review &#x00026; editing.</p></sec><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0060">The following is the Supplementary data to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.xml"><alt-text>Multimedia component 1</alt-text></media></supplementary-material></p></sec><fn-group><fn id="appsec2" fn-type="supplementary-material"><label>Appendix A</label><p id="p0065">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.rmcr.2020.101087" id="intref0055">https://doi.org/10.1016/j.rmcr.2020.101087</ext-link>.</p></fn></fn-group></back></article>